Monoclonal Antibodies The approach (s), which is/are currently followed to produce human monoclonal antibodies, is/are known as transformation of antigen specific B lymphocytes (EBV) all of these hybridization of 6-thioguanine-resistant human plasmacytoma with immune human lymphocytes combination of EB Vand hybridoma techniques transformation of antigen specific B lymphocytes (EBV) all of these hybridization of 6-thioguanine-resistant human plasmacytoma with immune human lymphocytes combination of EB Vand hybridoma techniques ANSWER DOWNLOAD EXAMIANS APP
Monoclonal Antibodies Some cross reactions with monoclonal antibodies (MAbs) can occur. Unexpected cross reactions occur more frequently with IgE IgG Ig MAbs IgA IgE IgG Ig MAbs IgA ANSWER DOWNLOAD EXAMIANS APP
Monoclonal Antibodies Preliminary clinical results with a humanized antibody against the interleukin-2 receptor have suggested the absence of human immune response against murine proteins (HAMA) response All of these presence of HAMA response poor recognition of immunoglobulin, Ig constant regions absence of human immune response against murine proteins (HAMA) response All of these presence of HAMA response poor recognition of immunoglobulin, Ig constant regions ANSWER DOWNLOAD EXAMIANS APP
Monoclonal Antibodies The cross linkage of antigens by antibodies is known as all of these a cross reaction complement fixation agglutination all of these a cross reaction complement fixation agglutination ANSWER DOWNLOAD EXAMIANS APP
Monoclonal Antibodies In monoclonal antibody technology, tumor cells that can replicate endlessly are fused with mammalian cells that produce an antibody. The result of this cell fusion is a myeloma lymphoblast hybridoma natural killer cell myeloma lymphoblast hybridoma natural killer cell ANSWER DOWNLOAD EXAMIANS APP
EXAMIANS